|
1
|
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
|
N Engl J Med
|
2004
|
7.67
|
|
2
|
Viral hepatitis in HIV infection.
|
N Engl J Med
|
2007
|
4.18
|
|
3
|
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
|
Hepatology
|
2005
|
2.91
|
|
4
|
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
|
Ann Intern Med
|
2013
|
1.82
|
|
5
|
Role of alphavbeta6 integrin in acute biliary fibrosis.
|
Hepatology
|
2007
|
1.80
|
|
6
|
New therapies for hepatitis C virus infection.
|
Clin Infect Dis
|
2009
|
1.46
|
|
7
|
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
|
Am J Gastroenterol
|
2004
|
1.43
|
|
8
|
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.
|
J Infect Dis
|
2010
|
1.28
|
|
9
|
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
|
Hepatology
|
2010
|
1.28
|
|
10
|
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
|
Gastroenterology
|
2005
|
1.26
|
|
11
|
Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
|
AIDS
|
2012
|
1.21
|
|
12
|
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
|
J Infect Dis
|
2013
|
1.18
|
|
13
|
Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
|
Radiology
|
2003
|
1.14
|
|
14
|
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
|
J Infect Dis
|
2011
|
1.13
|
|
15
|
Influence of cannabis use on severity of hepatitis C disease.
|
Clin Gastroenterol Hepatol
|
2008
|
1.08
|
|
16
|
De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
|
Clin Transplant
|
2006
|
0.99
|
|
17
|
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
|
J Acquir Immune Defic Syndr
|
2010
|
0.97
|
|
18
|
Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
|
Dig Dis Sci
|
2014
|
0.96
|
|
19
|
Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
|
Am J Kidney Dis
|
2009
|
0.95
|
|
20
|
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.
|
Clin Infect Dis
|
2012
|
0.93
|
|
21
|
Hepatitis resulting from liver-specific expression and recognition of self-antigen.
|
J Autoimmun
|
2008
|
0.92
|
|
22
|
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
|
Hepatology
|
2012
|
0.91
|
|
23
|
Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
|
J Infect Dis
|
2013
|
0.90
|
|
24
|
Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.
|
Liver Transpl
|
2005
|
0.90
|
|
25
|
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.
|
J Interferon Cytokine Res
|
2006
|
0.86
|
|
26
|
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.
|
Immunobiology
|
2010
|
0.85
|
|
27
|
Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children.
|
Clin Gastroenterol Hepatol
|
2011
|
0.85
|
|
28
|
Novel model of antigen-specific induction of bile duct injury.
|
Gastroenterology
|
2006
|
0.84
|
|
29
|
Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
|
AIDS
|
2015
|
0.83
|
|
30
|
Viral factors associated with cytokine expression during HCV/HIV co-infection.
|
J Interferon Cytokine Res
|
2007
|
0.83
|
|
31
|
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
|
J Acquir Immune Defic Syndr
|
2014
|
0.80
|
|
32
|
Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
|
Dig Dis Sci
|
2012
|
0.79
|
|
33
|
Hepatitis C and alcohol: fundamental and translational research directions.
|
Alcohol Clin Exp Res
|
2003
|
0.79
|
|
34
|
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
|
Clin Infect Dis
|
2007
|
0.78
|
|
35
|
Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
36
|
Antiviral therapy: nucleotide and nucleoside analogs.
|
Clin Liver Dis
|
2004
|
0.77
|
|
37
|
Eosinophilic hepatitis caused by lamotrigine.
|
Clin Gastroenterol Hepatol
|
2006
|
0.77
|
|
38
|
The challenge of diagnosing autoimmune hepatitis: less is more.
|
Hepatology
|
2008
|
0.76
|
|
39
|
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
40
|
Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
41
|
Survey of Asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members.
|
J Immigr Minor Health
|
2015
|
0.75
|
|
42
|
Sex differences in the association of HIV infection with hepatic steatosis.
|
AIDS
|
2016
|
0.75
|
|
43
|
Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.
|
J Acquir Immune Defic Syndr
|
2011
|
0.75
|
|
44
|
Controlled attenuation parameter and MR spectroscopy-measured liver steatosis are discordant in HIV-infected adults with high body mass.
|
AIDS
|
2017
|
0.75
|